Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

Detalles Bibliográficos
Autores principales:	Moran, A, Ramakrishnan, S, Borg, C, Connolly, C, Couillard, S, Mwasuku, C, Pavord, I, Hinks, T, Lehtimaki, L
Formato:	Conference item
Lenguaje:	English
Publicado:	European Respiratory Society 2020

Ejemplares similares